Autologous Blood Sequestration Using a Double Venous Reservoir Bypass Circuit and Polymerized Hemoglobin Prime

Cardiac surgery often necessitates transfusion of homologous blood. Hemoglobin based oxygen carrying solutions (HBOCs) transport oxygen, suggesting use in cardiopulmonary bypass. HBOC was used in a novel oxygenator double-reservoir circuit that permits acute sequestration of a portion of the autologous blood volume during bypass. Two groups of seven mongrel dogs each were studied in an experimental bypass model using global myocardial ischemia and cardioplegia protection: HBOC group, initial venous return drained to a separate reservoir and hypothermic bypass was conducted with HBOC containing perfusate in a second bypass reservoir; Control group, crystalloid prime in a conventional circuit. Hemodynamics and metabolic and hematologic parameters were measured before and 60 min after aortic clamp removal and reinfusion of sequestered autologous blood. Blood gases, base excess, hematocrit, total hemoglobin, and platelet counts were measured. In the HBOC group, metabolic acidosis did not occur, and ventricular function was preserved. Net conservation of platelets was noted at study conclusion: control 33 ± 13 × 103 per mm3versus HBOC 48 ± 13 × 103, p < 0.05. HBOC based priming in a double venous reservoir system permits bypass at very low hematocrit, with preservation of cardiac function. Net conservation of the platelet mass occurs, a portion of which is not exposed to the deleterious effects of hypothermia and cardiopulmonary bypass.

[1]  J. Berridge,et al.  Randomized Trial of Diaspirin Cross-linked Hemoglobin Solution as an Alternative to Blood Transfusion after Cardiac Surgery , 2000, Anesthesiology.

[2]  Simon C Watkins,et al.  Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. , 1998, Circulation.

[3]  R. Lee,et al.  Hemoglobin Based Oxygen Carrying Solution Stability in Extracorporeal Circulation An In Vitro Evaluation and Implications for Clinical Use , 1998, ASAIO journal.

[4]  J P AuBuchon,et al.  Platelet transfusion therapy. , 1996, Clinics in laboratory medicine.

[5]  J. Magovern,et al.  A model for predicting transfusion after coronary artery bypass grafting. , 1996, The Annals of thoracic surgery.

[6]  G. Vlahakes,et al.  Limitations of the efficacy of hemoglobin-based oxygen-carrying solutions. , 1995, Journal of applied physiology.

[7]  P. Slanetz,et al.  Hemoglobin blood substitutes in extended preoperative autologous blood donation: an experimental study. , 1994, Surgery.

[8]  B. Pasche,et al.  The platelet function defect of cardiopulmonary bypass. , 1993, Blood.

[9]  J. Guerrero,et al.  Ultra-pure polymerized bovine hemoglobin blood substitute: effects on the coronary circulation. , 1992, Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology.

[10]  G. Vlahakes,et al.  Hemodynamic effects and oxygen transport properties of a new blood substitute in a model of massive blood replacement. , 1990, The Journal of thoracic and cardiovascular surgery.

[11]  R. Mohr,et al.  The effect of transfusion of fresh whole blood versus platelet concentrates after cardiac operations. A scanning electron microscope study of platelet aggregation on extracellular matrix. , 1989, The Journal of thoracic and cardiovascular surgery.

[12]  R. Mohr,et al.  The hemostatic effect of transfusing fresh whole blood versus platelet concentrates after cardiac operations. , 1988, The Journal of thoracic and cardiovascular surgery.

[13]  R. Mohr,et al.  Effect of cardiac operation on platelets. , 1986, The Journal of thoracic and cardiovascular surgery.

[14]  R. Wilson,et al.  Hemostasis Changes During Cardiopulmonary Bypass Surgery , 1985, Seminars in thrombosis and hemostasis.

[15]  R. Bick Hemostasis Defects Associated with Cardiac Surgery, Prosthetic Devices, and Other Extracorporeal Circuits , 1985, Seminars in thrombosis and hemostasis.

[16]  N. Luban,et al.  Reduction of the volume of stored platelet concentrates for use in neonatal patients , 1984, Transfusion.

[17]  E. Hessel,et al.  Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release. , 1980, Blood.

[18]  C. Schiffer,et al.  Frozen autologous platelet transfusion for patients with leukemia. , 1978, The New England journal of medicine.

[19]  J. Arnold,et al.  A clinical safety trial of stroma‐free hemoglobin , 1978, Clinical pharmacology and therapeutics.

[20]  C. Schiffer,et al.  Platelet transfusion therapy for patients with leukemia. , 1978, Progress in clinical and biological research.

[21]  C. Valeri Circulation and Hemostatic Effectiveness of Platelets Stored at 4 C or 22 C: , 2003, Transfusion.

[22]  L. Harker,et al.  Preparation and Storage of Platelet Concentrates: I. FACTORS INFLUENCING THE HARVEST OF VIABLE PLATELETS FROM WHOLE BLOOD , 1976, British journal of haematology.

[23]  H. Oberman The indications for transfusion of freshly drawn blood. , 1967, JAMA.

[24]  T. R. White,et al.  Cerebellar ataxia presumed due to live, attenuated measles virus vaccine. , 1967, JAMA.

[25]  E. Salzman,et al.  The Use of ACD Bank Blood and Fresh Heparinized Blood in Open‐Heart Surgery: * , 1963, Transfusion.